Within-trial resource utilization and costs of patients randomized to treatment with imatinib (STI571) versus interferon-alpha (IFN-alpha) combined with cytarabine (Ara-C) in newly diagnosed patients with chronic myeloid leukemia in chronic phase.
Reed, SD; Radeva, JI; Glendenning, A; Schulman, KA
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
44th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date